Compare IRON & ZD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRON | ZD |
|---|---|---|
| Founded | 2017 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 1.9B |
| IPO Year | 2020 | 1999 |
| Metric | IRON | ZD |
|---|---|---|
| Price | $76.82 | $57.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 6 |
| Target Price | ★ $103.17 | $63.67 |
| AVG Volume (30 Days) | ★ 939.1K | 419.4K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 17.49 |
| Revenue | N/A | ★ $1,364,028,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.46 |
| P/E Ratio | ★ N/A | $3.23 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $40.00 | $22.45 |
| 52 Week High | $99.50 | $60.48 |
| Indicator | IRON | ZD |
|---|---|---|
| Relative Strength Index (RSI) | 64.49 | 52.50 |
| Support Level | $73.04 | $54.27 |
| Resistance Level | $83.09 | $57.48 |
| Average True Range (ATR) | 3.70 | 1.46 |
| MACD | 2.43 | 0.02 |
| Stochastic Oscillator | 81.23 | 56.20 |
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Ziff Davis Inc is a digital media and internet company operating a portfolio of brands across technology, shopping, gaming and entertainment, health and wellness, connectivity, and cybersecurity. The company has five reportable segments. The Technology & Shopping segment generates revenue from advertising and commerce content. The Gaming & Entertainment segment provides content, subscriptions, and digital storefront services. The Health & Wellness segment offers digital tools and content for health management. The Connectivity segment provides data and analytics solutions for network performance. The Cybersecurity & Martech segment delivers cloud-based software for security and marketing. It generates the majority of its revenue from the Health & Wellness segment.